Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbits

Circulation

Volumn 94, Issue 4, 1996, Pages 713-717

  Duverger, Nicolas ^a   Kruth, Howard ^b   Emmanuel, Florence ^a   Caillaud, Jean Michel ^a   Viglietta, Céline ^c   Castro, Graciela ^d   Tailleux, Anne ^d   Fievet, Catherine ^d   Fruchart, Jean Charles ^d   Houdebine, Louis Marie ^c   Denefle, Patrice ^a  

^a SANOFI   (France)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c CEMAGREF   (France)

^d INSTITUT PASTEUR DE LILLE   (France)

Author keywords

apolipoproteins; atherosclerosis lipoproteins; cholesterol

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; RABBIT; THORACIC AORTA; TRANSGENIC ANIMAL;

EID: 9544221670     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.4.713     Document Type: Article

References (38)

1. Buck RC, Rossiter RJ. Lipids of normal and atherosclerotic aortas. Arch Pathol. 1951;51:224-237.
2. Böttcher CJF, Woodford FP. Chemical changes in the arterial wall associated with atherosclerosis. Fed Proc. 1962;21(suppl 11):11-19.
3. Insull W Jr, Bartoch GE. Cholesterol, triglyceride, and phospholipid content of the intima, media and atherosclerotic fatty streak in human thoracic aorta. J Clin Invest. 1966;45:513-523.
4. Katz SS, Shipley GG, Small DM. Physical chemistry of the lipids of human atherosclerosis lesions: demonstration of a lesion intermediate between fatty streaks and advanced plaques. J Clin Invest. 1976;58:200-211.
5. Gordon DJ, Knoke J, Probsfield JL, Superko R, Tyroler HA. High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial. Circulation. 1986;74:1217-1225.
6. Miller NE. Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am Heart J. 1987;113:589-597.
7. Badimon JJ, Badimon L, Fuster V. Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. J Clin Invest. 1990;85:1234-1241.
8. Rubin EM, Krauss RM, Spangier EA, Verstuyft JG, Gift SM. Inhibition of early atherogenesis in transgenic mice by human apolipo-protein AI. Nature. 1991;353:265-267.
9. Paszty C, Maeda N, Verstuyft J, Rubin EM. Apolipoprotein Al trans-gene corrects apolipoprotein E deficiency-induced atherosclerosis in mice. J Clin Invest. 1994;94:899-903.
10. Plump AS, Scott CJ, Breslow JL. Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci U S A. 1994;91:9607-9611.
11. Liu AC, Lawn RM, Verstuyft JG, Rubin EM. Human apolipoprotein A-I prevents atherosclerosis associated with apolipoprotein[a] in transgenic mice. J Lipid Res. 1994;35:2263-2267.
12. Chapman JM. Comparative analysis of mammalian plasma lipoproteins. Methods Enzymol. 1986;128:71-147.
13. Nagashima M, McLean JW, Lawn RL. Cloning and mRNA tissue distribution of rabbit cholesteryl ester transfer protein. J Lipid Res. 1988;29:1643-1649.
14. Bocan TMA, Bak Mueller S, Uhlendorf PD, Newton RS, Krause BR. Comparison of CI-976, an ACAT inhibitor, and selected Hpid-lowering agents for antiatherosclerotic activity in iliac-femoral and thoracic aortic lesions: a biochemical, morphological, and morphometric evaluation. Arterioscler Thromb. 1991;11:1830-1843.
15. Tsukada T, Rosenfeld M, Ross R, Gow AM. Immunocytochemical analysis of cellular components in atherosclerotic lesions: use of monoclonal antibodies with the Watanabe and fat-fed rabbit. Arteriosclerosis. 1986;6:601-613.
16. Adams CMV, Miller NE, Morgan RS, Rao SN. Lipoprotein levels and tissue lipids in fatty-fibrous atherosclerosis induced in rabbits by two years' cholesterol feeding at a low level. Atherosclerosis. 1982;44:1-8.
17. Lupu F, Danaricu I, Simionescu N. Development of intracellular lipid deposits in the lipid-laden cells of atherosclerotic lesions: a cytochemical and ultrastructural study. Atherosclerosis. 1987;67:127-142.
18. Hunt CE, Duncan LA. Hyperlipoproteinaemia and atherosclerosis in rabbits fed low-level cholesterol and lecithin. Br J Exp Pathol. 1985;66:35-46.
19. Davies MJ. A critical analysis of animal models of atherosclerosis and restenosis. In: Conference proceedings of the Bristol-Myers Squibb Symposium on Cardiovascular Research, volume 10; 1993; Seattle, Wash. Abstract 1.
20. Chao FF, Blanchette-Mackie EJ, Dickens BJ, Gamble W, Kruth HS. Development of unesterified cholesterol rich lipid particles in atherosclerotic lesions of WHHL and cholesterol-fed rabbits. J Lipid Res. 1994;35:71-83.
21. Blankenhorn DH, Selzer RH, Crawford DW, Barth JB, Liu CR, Liu CH, Mack WJ, Alaupovic P. Beneficial effects of colestipol-niacin therapy on the common carotid artery: 2-year and 4-year reduction of intima-media thickness measured by ultrasound. Circulation. 1993;88:20-28.
22. Skinner MP, Yuan C, Mitsumori L, Hayes CE, Raines EW, Nelson JA, Ross R. Serial magnetic resonance imaging of experimental atherosclerosis detects lesion fine structure, progression and complications in vivo. Nat Med. 1995;1:69-73.
23. Duverger N, Viglietta C, Berthou L, Emmanuel F, Tailleux A, Parmentier-Nihoul L, Laine B, Fievet C, Castro G, Fruchart JC, Houdebine LM, Denèfle P. Transgenic rabbits expressing human apolipoprotein A-I in the liver. Arterioscler Thromb Vasc Biol. In press.
24. Pruvost I, Fievet C, Durieux C, Vu Dac N, Fruchart JC. Electroimmuno- and immunonephelometric assays of apolipoprotein A-I by using a mixture of monoclonal antibodies. Clin Chem. 1988;34:2048-2052.
25. Floch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipids from animals tissues. J Biol Chem. 1957;226:497-509.
26. Gamble W, Vaughan M, Kruth HS, Avigan J. Procedure for determination of free and total cholesterol in micro- or nanogram amounts suitable for studies with cultured cells. J Lipid Res. 1978;19:1068-1070.
27. Bartlett GR. Phosphorus assay in column chromatography. J Biol Chem. 1959;234:466-468.
28. de la Llera Moya M, Atger V, Paul JL, Fournier N, Moatti N, Giral P, Friday KE, Rothblat G. A cell culture system for screening human serum ability to promote cellular cholesterol efflux. Arterioscler Thromb. 1994;14:1056-1065.
29. Kubo M, Matsuzawa Y, Tajima S, Ishikawa K, Yamamoto A, Tarui S. ApoA-I and apoA-II inhibit hepatic triglyceride lipase from post human heparin plasma. Biochem Biophys Res Commun. 1981; 100:261-266.
30. Zhong S, Golberg IJ, Bruce C, Rubin E, Breslow JL, Tall A. Human apoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice. J Clin Invest. 1994;94:2457-2467.
31. 2-triacylglycerols. Biochim Biophys Acta. 1982;713:292-299.
32. Clay MA, Hopkins GJ, Ehnholm CP, Barter PJ. The rabbit as an animal model of hepatic lipase deficiency. Biochim Biophys Acta. 1989;1002:173-181.
33. Newnham HH, Hopkins GJ, Devlin S, Barter PJ. Lipoprotein lipase prevents the hepatic lipase-induced reduction in particle size of high density lipoproteins during incubation of human plasma. Atherosclerosis. 1990;82:167-176.
34. Olivecrona T, Bengtsson-Olivecrona G. Lipoprotein lipase and hepatic lipase. Curr Opin Lipidol. 1993;4:187-196.
35. Rothblat GH, Mahlberg FH, Johnson WJ, Phillips MC. Apolipoproteins, membrane cholesterol domains, and the regulation of cholesterol efflux. J Lipid Res. 1992;33:1091-1097.
36. Fielding CJ, Fielding PE. Molecular physiology of reverse cholesterol transport. J Lipid Res. 1995;36:211-228.
37. Castro GR, Fielding CJ. Early incorporation of cell-derived cholesterol into prebeta-migrating high density lipoprotein. Biochemistry. 1988;25:25-29.
38. Skarlatos SI, Duverger N, Rader D, Kruth HS. Cholesterol efflux from human monocyte-derived macrophages in the presence of LpA-I:A-II. Biochim Biophys Acta. 1995;1270:19-25.